Howard I. Scher

Top papers

• Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

  Howard I. Scher, Karim Fizazi, Fred Saad, et al.·2012·New England Journal of Medicine
  ↗ 4,554OA
• Abiraterone and Increased Survival in Metastatic Prostate Cancer

  Johann S. de Bono, Christopher J. Logothetis, Arturo Molina, et al.·2011·New England Journal of Medicine
  ↗ 4,377OA
• Tumor mutational load predicts survival after immunotherapy across multiple cancer types

  Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari, et al.·2019·Nature Genetics
  ↗ 4,323OA
• Integrative Genomic Profiling of Human Prostate Cancer

  Barry S. Taylor, Nikolaus Schultz, Haley Hieronymus, et al.·2010·Cancer Cell
  ↗ 3,775OA
• Integrative Clinical Genomics of Advanced Prostate Cancer

  Dan R. Robinson, Eliezer M. Van Allen, Yi-Mi Wu, et al.·2015·Cell
  ↗ 3,620OA
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

  Ahmet Zehir, Ryma Benayed, Ronak Shah, et al.·2017·Nature Medicine
  ↗ 3,477
• Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

  Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, et al.·2014·New England Journal of Medicine
  ↗ 3,013OA
• Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

  Charles J. Ryan, Matthew R. Smith, Johann S. de Bono, et al.·2012·New England Journal of Medicine
  ↗ 2,776OA
• Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

  Ethan Basch, Allison M. Deal, Mark G. Kris, et al.·2015·Journal of Clinical Oncology
  ↗ 2,610OA
• Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

  Chris Tran, Samedy Ouk, Nicola J. Clegg, et al.·2009·Science
  ↗ 2,305OA
• Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

  Ethan Basch, Allison M. Deal, Amylou C. Dueck, et al.·2017·JAMA
  ↗ 2,265OA
• Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

  Howard I. Scher, Susan Halabi, Ian F. Tannock, et al.·2008·Journal of Clinical Oncology
  ↗ 2,230OA